• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,913.50 -582.86
( -0.75%)
Global Indices
Nasdaq
48,888.32 -274.62
(-0.56%)
Dow Jones
7,157.73 -2.07
(-0.03%)
Hang Seng
59,153.23 -764.23
(-1.28%)
Nikkei 225
10,371.76 158.65
(1.55%)
Forex
USD-INR
94.52 0.35
(0.37%)
EUR-INR
110.65 0.18
(0.17%)
GBP-INR
127.71 0.18
(0.14%)
JPY-INR
0.59 0.00
(0.25%)

EQUITY - MARKET SCREENER

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
167.0814588
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
301.92
58725.49
EPS(TTM)
Face Value()
Div & Yield %
1.2
5
0.1
 
( Cr)
ParticularsDec 2025 ( Cr)Sep 2025 ( Cr)Jun 2025 ( Cr)
Gross Sales621.30583.30537.10
Other Operating Income0.000.000.00
Other Income 74.80133.8061.30
Total Income696.10717.10598.40
Total Expenditure 744.30530.40516.50
PBIDT-48.20186.7081.90
Interest 2.3067.2056.20
PBDT-50.50119.5025.70
Depreciation34.0033.8033.30
Tax8.903.201.10
Fringe Benefit Tax0.000.000.00
Deferred Tax-17.0011.60-0.40
Reported Profit After Tax-76.4070.90-8.30
Extra-ordinary Items -187.400.000.00
Adjusted Profit After Extra-ordinary item111.0070.90-8.30
EPS (Unit Curr.)-0.570.55-0.07
EPS (Adj) (Unit Curr.)-0.570.55-0.07
Calculated EPS (Unit Curr.)-0.570.53-0.06
Calculated EPS (Adj) (Unit Curr.)-0.570.53-0.06
Calculated EPS (Ann.) (Unit Curr.)-2.292.12-0.25
Calculated EPS (Adj) (Ann.) (Unit Curr.)-2.292.12-0.25
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity668.50668.50668.50
Reserve & Surplus0.000.000.00
Face Value5.005.005.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-7.7632.0115.25
PBDTM(%)-8.1320.494.78
PATM(%)-12.3012.15-1.55